Amlodipine Krka 10 mg Tablets
Authorisation PA1347/034/002 · KRKA, d.d., Novo mesto
- Licence holder
- KRKA, d.d., Novo mesto (all products →)
- Active substance
- Amlodipine
- Clinical trials
- 10 clinical trials →
- Dosage form
- Tablet
- Route of administration
- Oral use
- ATC codes
- C08CA, C08CA01
- First authorised
- 01/03/2013
- Prescription status
- Product subject to prescription which may be renewed (B)
- Supply
- Supply through pharmacies only
- Legal basis
- Generic application (Article 10(1) of Directive No 2001/83/EC)
Amlodipine: supply and approvals
154 authorised products on the HPRA list contain Amlodipine. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 18 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 18 Nov 2026)
- Germany (BfArM)
- 1 supply notice, e.g. Perindopril/Amlodipin Denk 4 mg/10 mg Tabletten (16 Jul 2025 to 15 Dec 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 13 years (since 1 March 2013). The HPRA list marks it as marketed in Ireland.
Other medicines with Amlodipine in Ireland
59 other products on the HPRA list contain Amlodipine, from 12 licence holders; 39 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Amlode 10 mg Tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Amlode 5 mg tablets | Rowex Limited, | National authorisation (PA) | Marketed |
| Amlodipine Clonmel 10 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amlodipine Clonmel 5 mg tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amlodipine Krka 5 mg Tablets | KRKA, d.d., Novo mesto | National authorisation (PA) | Marketed |
| Amlodipine Pinewood 10 mg tablets | Pinewood Laboratories Ltd | National authorisation (PA) | Marketed |
| Amlodipine Pinewood 5 mg Tablets | Pinewood Laboratories Ltd | National authorisation (PA) | Marketed |
| Amlodipine Teva 10 mg Tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Amlodipine Teva 5 mg Tablets | Teva Pharma B.V. | National authorisation (PA) | Marketed |
| Amlodipine/Valsartan Clonmel 10 mg/160 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amlodipine/Valsartan Clonmel 5 mg/160 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
| Amlodipine/Valsartan Clonmel 5 mg/80 mg film-coated tablets | Clonmel Healthcare Ltd | National authorisation (PA) | Marketed |
Other substances in ATC group C08CA
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 4 other active substances share the group C08CA with this product:
Lercanidipine hydrochloride (8) · Amlodipine besilate (6) · Felodipine (6) · Nimodipine (2)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
KRKA, d.d., Novo mesto holds 362 products on the HPRA list, with 117 different active substances; 189 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 19 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.